The PPD Podcast: Recent Episodes
PPD
In this podcast, Atul Chaudhari discuss the challenges and solutions in monitoring assay performance. He explores the benefits of qualification and validation when developing cell and virus neutralization assays for high throughput clinical testing and the best approach to maintain assay performance long-term without affecting the quality.
Speaker: Atul Chaudhari, Principal Scientist, PPD Clinical Research Services, Thermo Fisher Scientific
Exponential growth in the biotech and pharmaceutical industries plus the unprecedented expansion of different pharmaceutical therapies make it critical for companies to partner with a strategic contract laboratory to help meet all their outsourcing needs. Learn how GMP and CMC labs can help fulfill biotechs' needs with the latest platforms, technologies and instruments in this podcast with PPD’s Cathy Liloila and Jie Ding.
Speakers:
- Jie Ding - Senior Director, PPD® Laboratory Services, GMP Lab
- Catherine Liloia - Senior Director, PPD® Laboratory Services, GMP Lab
In this podcast, PPD expert Cathy Vrentas discusses how to leverage bioanalytical assays for gene therapy programs, key considerations in the development of these assays, and how the unique nature of gene therapies impact the development and maintenance of bioanalytical assays.
Speaker: Catherine (Cathy) Vrentas, senior research scientist, PPD® Laboratories bioanalytical lab
Dave Frakes, LuAnne Novello and Joseph Brennan discuss the topic of accelerating startup in early phase oncology studies in this most recent PPD podcast.
Dave Frakes, Mariah Baltezegar, Simon Coggins and Tim Rich discuss decentralized trial models in oncology clinical trials.
A discussion with Lymphoma Coalition CEO, Lorna Warwick, and PPD cell and gene therapy experts Dr. Panteli Theocharous and Ryan Michalek.
A discussion of the latest bioassay tools and techniques and their impact on drug development. Host Randy Buckwalter is joined by experts Cathy Liloia and Becky Garshick of PPD Laboratories.